315 related articles for article (PubMed ID: 10330313)
1. Chelated lead in relation to lead in bone and ALAD genotype.
Gerhardsson L; Börjesson J; Mattsson S; Schütz A; Skerfving S
Environ Res; 1999 May; 80(4):389-98. PubMed ID: 10330313
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
3. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
5. Assessment of how pregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotype women.
Montenegro MF; Barbosa F; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):347-51. PubMed ID: 18282196
[TBL] [Abstract][Full Text] [Related]
6. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
Schwartz BS; Lee BK; Stewart W; Sithisarankul P; Strickland PT; Ahn KD; Kelsey K
Occup Environ Med; 1997 Apr; 54(4):241-6. PubMed ID: 9166129
[TBL] [Abstract][Full Text] [Related]
7. Lead in finger bone, whole blood, plasma and urine in lead-smelter workers: extended exposure range.
Schütz A; Olsson M; Jensen A; Gerhardsson L; Börjesson J; Mattsson S; Skerfving S
Int Arch Occup Environ Health; 2005 Feb; 78(1):35-43. PubMed ID: 15750821
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
Cory-Slechta DA
J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
[TBL] [Abstract][Full Text] [Related]
9. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
Saxena G; Pathak U; Flora SJ
Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
Aslani MR; Najarnezhad V; Mohri M
Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
[TBL] [Abstract][Full Text] [Related]
11. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio.
Montenegro MF; Barbosa F; Sandrim VC; Gerlach RF; Tanus-Santos JE
Arch Toxicol; 2006 Jul; 80(7):394-8. PubMed ID: 16341691
[TBL] [Abstract][Full Text] [Related]
13. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
14. In vivo measurements of lead in fingerbone in active and retired lead smelters.
Börjesson J; Gerhardsson L; Schütz A; Mattsson S; Skerfving S; Osterberg K
Int Arch Occup Environ Health; 1997; 69(2):97-105. PubMed ID: 9001915
[TBL] [Abstract][Full Text] [Related]
15. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
16. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes.
Schwartz BS; Lee BK; Lee GS; Stewart WF; Simon D; Kelsey K; Todd AC
Environ Health Perspect; 2000 Oct; 108(10):949-54. PubMed ID: 11049814
[TBL] [Abstract][Full Text] [Related]
17. 24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study.
Soden SE; Lowry JA; Garrison CB; Wasserman GS
Clin Toxicol (Phila); 2007; 45(5):476-81. PubMed ID: 17503250
[TBL] [Abstract][Full Text] [Related]
18. Time-integrated blood lead concentration is a valid surrogate for estimating the cumulative lead dose assessed by tibial lead measurement.
Roels H; Konings J; Green S; Bradley D; Chettle D; Lauwerys R
Environ Res; 1995 May; 69(2):75-82. PubMed ID: 8608773
[TBL] [Abstract][Full Text] [Related]
19. Lead concentrations in cortical and trabecular bones in deceased smelter workers.
Gerhardsson L; Akantis A; Lundström NG; Nordberg GF; Schütz A; Skerfving S
J Trace Elem Med Biol; 2005; 19(2-3):209-15. PubMed ID: 16325538
[TBL] [Abstract][Full Text] [Related]
20. [Study on relationships between biomarkers in workers with low-level occupational lead exposure].
Yang H; Zhang H; Zhou Q; Gong W; Zhu B; Li W; Zhou Y
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Jun; 33(6):403-8. PubMed ID: 26653370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
